NILSYNOC Trademark

Trademark Overview

On Friday, December 17, 2021, a trademark application was filed for NILSYNOC with the United States Patent and Trademark Office. The USPTO has given the NILSYNOC trademark a serial number of 97177099. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Tuesday, July 30, 2024. This trademark is owned by Xspray Pharma AB. The NILSYNOC trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of cancer
nilsynoc

General Information

Serial Number97177099
Word MarkNILSYNOC
Filing DateFriday, December 17, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateTuesday, July 30, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 14, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment and prevention of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 21, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameXspray Pharma AB
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSolna SE-16967
SE
Party NameXspray Pharma AB
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSolna SE-16967
SE

Trademark Events

Event DateEvent Description
Tuesday, December 21, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 21, 2021NEW APPLICATION ENTERED
Monday, May 9, 2022ASSIGNED TO EXAMINER
Monday, May 9, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 25, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 14, 2022PUBLISHED FOR OPPOSITION
Tuesday, June 14, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, January 9, 2023SOU EXTENSION 1 FILED
Tuesday, August 9, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, January 9, 2023SOU TEAS EXTENSION RECEIVED
Monday, January 9, 2023SOU EXTENSION 1 GRANTED
Wednesday, January 11, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 21, 2023SOU EXTENSION 2 FILED
Friday, July 21, 2023SOU TEAS EXTENSION RECEIVED
Friday, July 21, 2023SOU EXTENSION 2 GRANTED
Tuesday, July 30, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, July 30, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 30, 2024SOU EXTENSION 4 GRANTED
Tuesday, July 30, 2024SOU EXTENSION 4 FILED
Thursday, January 11, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 25, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 9, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, January 9, 2024SOU EXTENSION 3 FILED
Tuesday, January 9, 2024SOU EXTENSION 3 GRANTED

Related Keywords

nilsynoc cancer prevention treatment preparations pharmaceutical